Thanks, Jon, and good evening everyone. I'll provide a more detailed overview of our Q1 2023 financial performance and then turn it back to Jon, before we open up the call for questions. Unless stated otherwise, all of the comparisons and various commentary is on a year-over-year basis. Net sales increased 13%, to $95.3 million compared to $84.2 million. As Jon mentioned, the increase was driven by strong sales execution and demand from traditional financial institutions as well as fintechs for our premium payment cards. Gross margin for the quarter was 56% compared to 58% in prior year. While this was due to higher material costs, it is in-line with our previously mentioned and long-term gross margin expectations are being in the mid-50% range. Net income was $10.7 million compared to $26.9 million. Net income in the first quarter of 2023 was impacted by non-cash expenses. Including $13.4 million related to the fair value of company's warrants, earnout consideration and derivative liabilities, which was driven by the improvement in our stock price. It also was impacted by $4 million of stock-based compensation. Adjusted EBITDA in Q1 was $35.5 million, up 6% compared to $33.3 million last year. And adjusted EBITDA margin in Q1 was 37% compared to 40% in the first quarter of 2022. The decrease in adjusted EBITDA margin was driven by lower gross margins and our continued investment in the Arculus business and building out infrastructure. Adjusted EBITDA includes the net expense investment in Arculus of $4.5 million. However, it excludes both the non-cash revaluation adjustments, which were driven by our strong stock price and stock compensation expense. Looking at the split between domestic and international, you can see we continue to have strong domestic sales, increasing 18% compared to the first quarter of 2022, to $74 million, again, due to the strength of our sales execution and favorable industry trends. International net sales for the first quarter of 2023, was $22 million returning to a roughly 20% mix and in-line with our long range view of this business. Turning to our balance sheet at March 31, 2023 which you'll find in the appendix. We continue to build our inventory stocks based on the strong demand we are seeing and to stay ahead of any supply chain issues. We have a track record of turning our inventory over 10 times each year, while the absolute value has grown. We had cash and cash equivalents of $23 million and total debt of $363 million which includes approximately $233 million of term loan, and a $130 million of exchangeable notes. This results in a total net debt of $340 million. We want to provide both our overall debt leverage and our bank agreement secured debt leverage as our bank agreement is calculated with slight differences. At March 31, our overall leverage ratio improved to 2.5 times based on a net debt of $340 million and trailing 12-month adjusted EBITDA of $138 million. This compares to 3.7 times at March 31, 2022 with the improvement driven by a combination of paying down debt and growing adjusted EBITDA. At March 31, 2023, we had a bank agreement secured debt leverage ratio of 1.6 times based on a total secured debt of $233 million and trailing 12-month adjusted bank EBITDA of $146 million. This compares to 2.5 times at March 31, 2022. Taking a look at our cash flow statement, as Jon mentioned, we generated operating cash flow of $25 million during the first quarter. We continue to believe our cash balances, cash flow generation and debt facilities provide us with more than enough adequate working capital to fund our operations. I want to turn now to earnings per share. As a reminder, our method under GAAP for calculating basic and diluted EPS allows us to allocate changes in adjustments of the mark-to-market instruments, among the public company and the operating subsidiaries, to better reflect the actual economic impact of conversion of such instruments, on the net income on a per share basis. Having said that, let me run through the EPS calculations. GAAP EPS for the three months ended March 31, 2023 was $0.13 per basic share, and $0.11 per diluted share. This compares to $0.23 per basic and diluted share in the year ago period. As I mentioned earlier, the decline was primarily attributable to a change in the fair value of our warrants, earnout consideration and derivative liabilities, which was driven by the appreciation in our stock price. You can read through the footnotes on the slide, that take you through the complexities of the allocation of net income due to the Up-C structure and the shares that are included in the basic and diluted calculations. Note that the fair value adjustments in the quarter have been allocated among the companies, to come to pre-allocation net income. Now, for non-GAAP earnings per share. On slide 17 and in our MD&A, we are also providing a non-GAAP adjusted net income and adjusted EPS, which excludes the impact of non-cash fair value adjustments on our warrants, earnout revaluation and stock comp. We believe that this provides a clearer picture of the economics of the company's operating results. Please note that these non-cash adjustments can have both a positive and a negative impact on net income. With that background, our non-GAAP EPS for Q1 2023 was $0.27 per basic share, and $0.23 per diluted share. This was flat compared to $0.27 per basic share, and $0.23 per diluted share in the year ago period. In the appendix, you'll find a reconciliation between the GAAP and non-GAAP net income used in these calculations. I'll now hand it back over to Jon for a final summary before we take questions.